US Stock MarketDetailed Quotes
ABCL AbCellera Biologics
- 2.760
- +0.040+1.47%
Close Nov 22 16:00 ET
- 2.790
- +0.030+1.09%
Pre 08:05 ET
815.21MMarket Cap-4524P/E (TTM)
2.830High2.710Low1.81MVolume2.740Open2.720Pre Close5.02MTurnover0.96%Turnover RatioLossP/E (Static)295.37MShares6.05552wk High0.76P/B522.34MFloat Cap2.33552wk Low--Dividend TTM189.25MShs Float71.910Historical High--Div YieldTTM4.41%Amplitude2.335Historical Low2.776Avg Price1Lot Size
AbCellera Biologics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.39%6.51M | -27.18%7.32M | -18.36%9.95M | -92.17%38.03M | -57.40%9.18M | -93.49%6.6M | -78.10%10.06M | -96.15%12.19M | 29.38%485.42M | -84.54%21.55M |
| Operating revenue | -1.39%6.51M | -27.18%7.32M | -18.36%9.95M | -92.17%38.03M | -57.40%9.18M | -93.49%6.6M | -78.10%10.06M | -96.15%12.19M | 29.38%485.42M | -84.54%21.55M |
| Cost of revenue | 0 | 45.96%66.44M | -92.90%1.55M | |||||||
| Gross profit | -90.92%38.03M | 27.09%418.99M | -82.98%19.99M | |||||||
| Operating expense | 64.81%96.68M | 71.39%97.47M | -16.45%61.57M | 36.03%261.08M | 28.10%71.86M | 26.25%58.66M | 19.55%56.87M | 76.30%73.69M | 78.06%191.92M | 83.48%56.09M |
| Selling and administrative expenses | 24.92%22.28M | 20.48%23.33M | 9.58%20.72M | 12.62%75.18M | 21.44%19.07M | 5.66%17.84M | 10.44%19.36M | 13.63%18.91M | 36.90%66.76M | 6.72%15.71M |
| -Selling and marketing expense | -9.60%3.14M | -18.35%3.14M | -10.77%3.37M | 25.82%14.18M | 15.20%3.1M | 12.27%3.47M | 23.11%3.84M | 59.11%3.77M | 63.03%11.27M | 47.29%2.69M |
| -General and administrative expense | 33.25%19.15M | 30.09%20.19M | 14.66%17.35M | 9.94%61M | 22.74%15.97M | 4.18%14.37M | 7.69%15.52M | 6.07%15.13M | 32.59%55.49M | 0.97%13.02M |
| Research and development costs | 8.05%40.97M | 12.21%40.93M | -25.38%39.29M | 62.83%175.66M | 72.14%48.62M | 42.64%37.92M | 36.68%36.47M | 99.68%52.65M | 73.82%107.88M | 64.13%28.25M |
| Depreciation amortization depletion | 543.75%36.92M | 551.02%36.52M | -12.15%4.84M | -12.38%24.4M | -45.46%7.54M | 11.36%5.74M | 14.82%5.61M | 38.20%5.51M | 92.67%27.84M | 249.12%13.82M |
| -Depreciation and amortization | 543.75%36.92M | 551.02%36.52M | -12.15%4.84M | -12.38%24.4M | -45.46%7.54M | 11.36%5.74M | 14.82%5.61M | 38.20%5.51M | 92.67%27.84M | 249.12%13.82M |
| Other operating expenses | -23.44%-3.49M | 27.67%-3.31M | 2.93%-3.28M | -34.12%-14.16M | -101.55%-3.38M | -31.53%-2.83M | -198.11%-4.58M | 35.04%-3.37M | 39.64%-10.55M | 68.47%-1.68M |
| Operating profit | -73.20%-90.17M | -92.56%-90.14M | 16.07%-51.62M | -198.23%-223.05M | -73.61%-62.68M | -230.53%-52.06M | -582.31%-46.81M | -126.72%-61.5M | 2.33%227.07M | -141.56%-36.1M |
| Net non-operating interest income expense | -10.59%9.6M | -9.07%9.8M | 6.58%10.4M | 162.75%42.25M | 29.50%10.97M | 93.30%10.74M | 662.31%10.78M | 1,367.52%9.76M | 382.85%16.08M | 8.47M |
| Non-operating interest income | -10.59%9.6M | -9.07%9.8M | 6.58%10.4M | 162.75%42.25M | 29.50%10.97M | 93.30%10.74M | 662.31%10.78M | 1,367.52%9.76M | 382.85%16.08M | --8.47M |
| Other net income (expense) | 776.69%17.94M | 1,732.28%32.16M | -142.55%-1.53M | 267.52%6.78M | 182.19%3.11M | 78.53%2.05M | -36.90%-1.97M | 3.59M | 33.47%-4.05M | 31.10%-3.78M |
| Other non- operating income (expenses) | 776.69%17.94M | 1,732.28%32.16M | -142.55%-1.53M | 267.52%6.78M | 182.19%3.11M | 78.53%2.05M | -36.90%-1.97M | --3.59M | 33.47%-4.05M | 31.10%-3.78M |
| Income before tax | -59.47%-62.63M | -26.79%-48.19M | 11.22%-42.75M | -172.79%-174.03M | -54.72%-48.6M | -184.31%-39.28M | -451.90%-38M | -120.86%-48.15M | 9.10%239.1M | -137.08%-31.41M |
| Income tax | -8.05%-11.53M | -50.58%-11.26M | 73.41%-2.14M | -134.29%-27.63M | 4.41%-1.45M | -153.43%-10.67M | -7,301.98%-7.48M | -112.92%-8.04M | 22.68%80.58M | -106.13%-1.52M |
| Net income | -78.63%-51.11M | -20.97%-36.93M | -1.25%-40.61M | -192.35%-146.4M | -57.73%-47.15M | -207.46%-28.61M | -349.93%-30.53M | -123.79%-40.11M | 3.29%158.52M | -149.86%-29.89M |
| Net income continuous Operations | -78.63%-51.11M | -20.97%-36.93M | -1.25%-40.61M | -192.35%-146.4M | -57.73%-47.15M | -207.46%-28.61M | -349.93%-30.53M | -123.79%-40.11M | 3.29%158.52M | -149.86%-29.89M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -78.63%-51.11M | -20.97%-36.93M | -1.25%-40.61M | -192.35%-146.4M | -57.73%-47.15M | -207.46%-28.61M | -349.93%-30.53M | -123.79%-40.11M | 3.29%158.52M | -149.86%-29.89M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -78.63%-51.11M | -20.97%-36.93M | -1.25%-40.61M | -192.35%-146.4M | -57.73%-47.15M | -207.46%-28.61M | -349.93%-30.53M | -123.79%-40.11M | 3.29%158.52M | -149.86%-29.89M |
| Basic earnings per share | -70.00%-0.17 | -18.18%-0.13 | 0.00%-0.14 | -191.07%-0.51 | -70.00%-0.17 | -211.11%-0.1 | -450.00%-0.11 | -123.73%-0.14 | 0.00%0.56 | -145.45%-0.1 |
| Diluted earnings per share | -70.00%-0.17 | -18.18%-0.13 | 0.00%-0.14 | -202.00%-0.51 | -70.00%-0.17 | -225.00%-0.1 | -450.00%-0.11 | -125.93%-0.14 | 4.17%0.5 | -152.63%-0.1 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data